Publication date: Available online 4 November 2026 Source: Journal of Hospital Infection Author(s): Hannah Higgins, Rebecca L. Guy, Hannah E. Emmett, Andre Charlett, Jocelyn Elmes, Alicia Demirjian, Rachel Freeman, Katherine L. Henderson, Wendy Rice, Dimple Y. Chudasama, Jasmin Islam, Jacquelyn McCormick, Russell Hope, Colin S. Brown, Sarah Gerver
Carbapenemase-producing Enterobacterales in intensive care units: England 2022 point-prevalence survey. // Journal of Hospital Infection. – URL: https://www.sciencedirect.com/science/article/pii/S0195670126004329?dgcid=rss_sd_all
Carbapenemase-producing Enterobacterales in intensive care units: England 2022 point-prevalence survey. Journal of Hospital Infection. https://www.sciencedirect.com/science/article/pii/S0195670126004329?dgcid=rss_sd_all
“Carbapenemase-producing Enterobacterales in intensive care units: England 2022 point-prevalence survey.” Journal of Hospital Infection.
@article{article54004,
title = {Carbapenemase-producing Enterobacterales in intensive care units: England 2022 point-prevalence survey},
journal = {Journal of Hospital Infection},
url = {https://www.sciencedirect.com/science/article/pii/S0195670126004329?dgcid=rss_sd_all}
}
ABSTRACT Background Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an...
ABSTRACT Background The lipid‐dependent yeast genus Malassezia is composed of skin commensals that can become pathogenic. This genus can cause bloodstream infection in low‐weight preterm neonates and immunocompromised adults. However,...